Sana Biotechnology will lay off 29% of workforce
GeekWire
OCTOBER 10, 2023
Sana Biotechnology will reduce its workforce by 29%, the Seattle-based cell and gene therapy company revealed in a SEC filing Tuesday. Sana, which went public in 2021, said it will continue development of its manufacturing facility in Bothell, Wash. It reported a net loss of $114 million in its most recent second quarter.
Let's personalize your content